08.05.2013 11:20 Uhr, Quelle: Wallstreet online

DGAP-News: PAION AG: RECRUITMENT OF PHASE II/III STUDY WITH SHORT-ACTING ANAESTHETIC/SEDATIVE REMIMAZOLAM (ONO'S DEVELOPMENT CODE: ONO-2745) IN JAPAN IS COMPLETED

DGAP-News: PAION AG / Key word(s): Research Update PAION AG: RECRUITMENT OF PHASE II/III STUDY WITH SHORT-ACTING ANAESTHETIC/SEDATIVE REMIMAZOLAM (ONO'S DEVELOPMENT CODE: ONO-2745) IN JAPAN IS COMPLETED 08.05.2013 / …

Weiterlesen bei Wallstreet online